Stock Scorer
Stock Board CompareNew Screen Insiders ETFNew
Donate
…
Report Measures Companies Earnings calendar Insider buying Fund portfolios Congress trades ETFs
Sign in

Medicon Hellas S.A. (MEDIC.AT)

Every figure this model derived for MEDIC.AT, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 1,500,297 PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities 2025-12-31
cash 10,676,974 CashAndCashEquivalents 2026-01-01
current assets 22,683,651 CurrentAssets 2026-01-01
current liabilities 4,375,086 CurrentLiabilities 2026-01-01
equity 19,764,408 Equity 2026-01-01
interest expense 457,481 FinanceCosts 2025-12-31
ocf 4,410,356 CashFlowsFromUsedInOperatingActivities 2025-12-31
revenue 17,954,321 Revenue 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up MEDIC.AT on one particular measure came for.

RatioValue
cash operating margin21.02
current ratio5.18
current ratio reported5.18
ebit cagr-18.02
ebit yoy37.75
ev ebit1.32
ev owner earnings1.02
ev sales0.17
fcf margin16.21
growth cv3.91
interest cover4.94
operating margin12.58
owner earnings margin16.21
revenue growth-0.94
revenue growth per share-0.94
roic19.64
rule of 4011.65
sbc pct revenue0.0

Everything else this filing tags

97 more elements from MEDIC.AT's own XBRL that this model has no measure for, newest reading each, largest first. Nothing here is converted, added up or renamed — it is the filing's own element names and the filing's own numbers.

ElementNewestAs of PeriodsUnit
Assets32,687,4012026-01-01 6EUR
EquityAndLiabilities32,687,4012026-01-01 6EUR
GrossProfit13,113,9852025-12-31 6EUR
CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition10,676,9742026-01-01 5EUR
NoncurrentAssets10,003,7502026-01-01 6EUR
NoncurrentLiabilities8,547,9072026-01-01 6EUR
LongTermBorrowingsAndNonCurrentLeaseLiabilities8,163,7892026-01-01 6EUR
PropertyPlantAndEquipment7,293,1302026-01-01 6EUR
CurrentTradeReceivables7,251,4192026-01-01 6EUR
IssuedCapital6,982,9932026-01-01 6EUR
RetainedEarnings6,771,0682026-01-01 6EUR
SellingExpense6,700,1352025-12-31 6EUR
OtherReserves5,541,5502026-01-01 6EUR
CostOfSales4,840,3352025-12-31 6EUR
OtherCurrentFinancialAssets4,000,0002026-01-01 4EUR
OtherCurrentAssets4,000,0002026-01-01 2EUR
ProfitLossFromOperatingActivitiesBeforeInterestTaxesDepreciationAndAmortisationExpense3,773,4562025-12-31 6EUR
Inventories3,512,3842026-01-01 6EUR
AdministrativeExpense3,186,5592025-12-31 6EUR
TradeAndOtherCurrentPayables2,974,7992026-01-01 6EUR
DeferredTaxAssets2,642,3702026-01-01 6EUR
AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables2,313,8222025-12-31 6EUR
ProfitLossFromOperatingActivities2,259,3632025-12-31 6EUR
IncreaseDecreaseInCashAndCashEquivalents2,164,2272025-12-31 6EUR
ProfitLossBeforeTax2,071,3442025-12-31 6EUR
ProfitLossBeforeTaxContinuingOperations2,071,3442025-12-31 3EUR
ComprehensiveIncome1,769,6682025-12-31 6EUR
ProfitLoss1,768,5682025-12-31 12EUR
ProfitLossFromContinuingOperations1,768,5682025-12-31 3EUR
ComprehensiveIncomeFromContinuingOperationsAttributableToOwnersOfParent1,733,1712025-12-31 3EUR
IncomeFromContinuingOperationsAttributableToOwnersOfParent1,732,4382025-12-31 3EUR
DepreciationAndAmortisationExpense1,514,0932025-12-31 6EUR
AdjustmentsForDepreciationAndAmortisationExpense1,514,0932025-12-31 6EUR
ComprehensiveIncomeAttributableToOwnersOfParent1,358,0312023-12-31 4EUR
CashFlowsFromUsedInInvestingActivities-1,320,8352025-12-31 6EUR
OtherCurrentReceivables1,242,8742026-01-01 6EUR
ShortTermBorrowingsAndCurrentLeaseLiabilities1,078,1262026-01-01 6EUR
IncomeTaxesPaidClassifiedAsOperatingActivities1,051,0722025-12-31 6EUR
ResearchAndDevelopmentExpense1,043,6032025-12-31 6EUR
AdjustmentsForDecreaseIncreaseInInventories-943,6702025-12-31 6EUR
AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables942,7452025-12-31 6EUR
CashFlowsFromUsedInFinancingActivities-925,2942025-12-31 6EUR
DividendsPaidClassifiedAsFinancingActivities574,5502025-12-31 6EUR
IncreaseDecreaseThroughOtherDistributionsToOwners574,5502025-12-31 4EUR
AdjustmentsForFinanceCosts457,4812025-12-31 6EUR
RepaymentsOfBorrowingsClassifiedAsFinancingActivities344,6412025-12-31 6EUR
NoncurrentProvisionsForEmployeeBenefits325,4242026-01-01 6EUR
OtherIncome324,2842025-12-31 6EUR
CurrentTaxLiabilities322,1622026-01-01 4EUR
CurrentTaxLiabilitiesCurrent306,9672023-01-01 3EUR
IncomeTaxExpenseContinuingOperations302,7762025-12-31 6EUR
PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities300,7852025-12-31 6EUR
NoncontrollingInterests295,7002026-01-01 6EUR
ProceedsFromLeaseLiabilitiesClassifiedAsFinancingActivities294,6822025-12-31 6EUR
FinanceIncome269,4622025-12-31 6EUR
AdjustmentsForFinanceIncome269,4622025-12-31 6EUR
OtherGainsLosses-248,6112025-12-31 6EUR
AdjustmentsForIncreaseInProvisions-242,7702025-12-31 6EUR
IncreaseDecreaseThroughDisposalOfSubsidiary-231,1732024-12-31 1EUR
InterestPaidClassifiedAsOperatingActivities217,3622025-12-31 6EUR
DividendsPaid202,3952022-12-31 2EUR
SharePremium173,0962026-01-01 6EUR
InterestReceivedClassifiedAsInvestingActivities133,6792025-12-31 6EUR
ProfitLossAttributableToNoncontrollingInterests121,8352023-12-31 4EUR
ComprehensiveIncomeAttributableToNoncontrollingInterests121,2462023-12-31 4EUR
AdjustmentsForGainOnDisposalsPropertyPlantAndEquipment119,8932025-12-31 6EUR
AdjustmentsForDecreaseInProvisions112,7892025-12-31 6EUR
AdjustmentsForLossOnDisposalsPropertyPlantAndEquipment67,8892025-12-31 6EUR
DeferredTaxLiabilities58,6942026-01-01 6EUR
ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities45,7832025-12-31 6EUR
IntangibleAssetsAndGoodwill38,1002026-01-01 6EUR
ComprehensiveIncomeFromContinuingOperationsAttributableToNoncontrollingInterests36,4972025-12-31 3EUR
ProfitLossFromContinuingOperationsAttributableToNoncontrollingInterests36,1302025-12-31 3EUR
OtherNoncurrentReceivables30,1502026-01-01 6EUR
OtherComprehensiveIncomeBeforeTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans1,4102025-12-31 6EUR
OtherComprehensiveIncome1,1002025-12-31 6EUR
IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome3102025-12-31 6EUR
BasicEarningsLossPerShareFromContinuingOperations02025-12-31 6EUR/shares
CurrentFinancialAssetsAtFairValueThroughProfitOrLoss02024-01-01 4EUR
OtherNoncurrentLiabilities02025-01-01 5EUR
IncreaseDecreaseThroughTransferToStatutoryReserve02025-12-31 3EUR
IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl02023-12-31 2EUR
IncreaseDecreaseThroughTransfersAndOtherChangesEquity02025-12-31 3EUR
ProceedsFromSalesOfInvestmentsOtherThanInvestmentsAccountedForUsingEquityMethod02025-12-31 5EUR
DividendsReceivedClassifiedAsInvestingActivities02024-12-31 3EUR
ProfitLossBeforeTaxDiscontinuedOperations02025-12-31 3EUR
TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations-02025-12-31 3EUR
ProfitLossFromDiscontinuedOperations02025-12-31 3EUR
IncomeFromDiscontinuedOperationsAttributableToOwnersOfParent02025-12-31 3EUR
ProfitLossFromDiscontinuedOperationsAttributableToNoncontrollingInterests02025-12-31 3EUR
ComprehensiveIncomeFromDiscontinuedOperationsAttributableToOwnersOfParent02025-12-31 3EUR
ComprehensiveIncomeFromDiscontinuedOperationsAttributableToNoncontrollingInterests02025-12-31 3EUR
BasicEarningsLossPerShareFromDiscontinuedOperations02025-12-31 3EUR/shares
CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations02025-12-31 3EUR
CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations02025-12-31 3EUR
CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations02025-12-31 3EUR
IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations02025-12-31 3EUR

What to be careful about

What this model itself distrusts about MEDIC.AT's figures. Written by the derivation as it ran, not added afterwards.